BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24648164)

  • 1. Hepatocellular carcinoma targeting agents: conjugates of nitroimidazoles with trimethyl nordihydroguaiaretic acid.
    Hsu MH; Wu SC; Pao KC; Unlu I; Gnabre JN; Mold DE; Huang RC; Hwu JR
    ChemMedChem; 2014 May; 9(5):1030-7. PubMed ID: 24648164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of phenyl substituted polyoxygenated xanthone derivatives as anti-hepatoma agents.
    Dai M; Yuan X; Kang J; Zhu ZJ; Yue RC; Yuan H; Chen BY; Zhang WD; Liu RH; Sun QY
    Eur J Med Chem; 2013 Nov; 69():159-66. PubMed ID: 24013415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylated nordihydroguaiaretic acids as anti-cancer agents.
    Hwu JR; Hsu CI; Hsu MH; Liang YC; Huang RC; Lee YC
    Bioorg Med Chem Lett; 2011 Jan; 21(1):380-2. PubMed ID: 21123067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity.
    Duan YT; Yao YF; Huang W; Makawana JA; Teraiya SB; Thumar NJ; Tang DJ; Tao XX; Wang ZC; Jiang AQ; Zhu HL
    Bioorg Med Chem; 2014 Jun; 22(11):2947-54. PubMed ID: 24792811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nitroimidazole alkylsulfonamides as hypoxic cell radiosensitisers.
    Bonnet M; Hong CR; Gu Y; Anderson RF; Wilson WR; Pruijn FB; Wang J; Hicks KO; Hay MP
    Bioorg Med Chem; 2014 Apr; 22(7):2123-32. PubMed ID: 24650701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
    Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
    Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
    Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
    Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
    Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
    Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma.
    Omar HA; Zaher DM; Srinivasulu V; Hersi F; Tarazi H; Al-Tel TH
    Eur J Med Chem; 2017 Oct; 139():804-814. PubMed ID: 28865276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
    Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
    J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schiff's base derivatives bearing nitroimidazole and quinoline nuclei: new class of anticancer agents and potential EGFR tyrosine kinase inhibitors.
    Makawana JA; Sangani CB; Lin L; Zhu HL
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1734-6. PubMed ID: 24630412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
    Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
    J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
    Zhang H; Zhu P; Liu J; Yang X; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
    Eur J Med Chem; 2014 Nov; 87():159-67. PubMed ID: 25247772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-obatoclax derivative complexes mediate DNA cleavage and exhibit anti-cancer effects in hepatocellular carcinoma.
    Su JC; Chang JH; Huang JW; Chen PP; Chen KF; Tseng PH; Shiau CW
    Chem Biol Interact; 2015 Feb; 228():108-13. PubMed ID: 25598309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
    Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
    Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid.
    Hernández-Damián J; Andérica-Romero AC; Pedraza-Chaverri J
    Arch Pharm (Weinheim); 2014 Oct; 347(10):685-97. PubMed ID: 25100573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro anticancer activity of zinc(II) phthalocyanines conjugated with coumarin derivatives for dual photodynamic and chemotherapy.
    Zhou XQ; Meng LB; Huang Q; Li J; Zheng K; Zhang FL; Liu JY; Xue JP
    ChemMedChem; 2015 Feb; 10(2):304-11. PubMed ID: 25369981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization, and anti-melanoma activity of tetra-O-substituted analogs of nordihydroguaiaretic acid.
    Meyers RO; Lambert JD; Hajicek N; Pourpak A; Kalaitzis JA; Dorr RT
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4752-5. PubMed ID: 19615898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma.
    Ding Y; Li S; Ge W; Liu Z; Zhang X; Wang M; Chen T; Chen Y; Zhang Q
    Eur J Med Chem; 2019 Dec; 183():111706. PubMed ID: 31553932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.